-
1
-
-
0033511781
-
Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women
-
Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE. Guidelines. for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis 1999;29:745-58. (Pubitemid 30256361)
-
(1999)
Clinical Infectious Diseases
, vol.29
, Issue.4
, pp. 745-758
-
-
Warren, J.W.1
Abrutyn, E.2
Richard Hebel, J.3
Johnson, J.R.4
Schaeffer, A.J.5
Stamm, W.E.6
-
2
-
-
0037074321
-
National patterns in the treatment of urinary tract infections in women by ambulatory care physicians
-
Huang ES, Stafford RS. National patterns in the treatment of urinary tract infections in women by ambulatory care physicians. Archives of internal medicine 2002;162:41-7. (Pubitemid 34073399)
-
(2002)
Archives of Internal Medicine
, vol.162
, Issue.1
, pp. 41-47
-
-
Huang, E.S.1
Stafford, R.S.2
-
3
-
-
1342288921
-
Longer than recommended empiric antibiotic treatment of urinary tract infection in women: An avoidable waste of money
-
DOI 10.1111/j.1365-2710.2003.00537.x
-
Kahan NR, Chinitz DP, Kahan E. Longer than recommended empiric antibiotic treatment of urinary tract infection in women: an avoidable waste of money. Journal of clinical pharmacy and therapeutics 2004;29:59-63. (Pubitemid 38253538)
-
(2004)
Journal of Clinical Pharmacy and Therapeutics
, vol.29
, Issue.1
, pp. 59-63
-
-
Kahan, N.R.1
Chinitz, D.P.2
Kahan, E.3
-
5
-
-
0030253882
-
Mechanism of action and impact of a cystitis clinical practice guideline on outcomes and costs of care in an HMO
-
O'Connor PJ, Solberg LI, Christianson J, Amundson G, Mosser G. Mechanism of action and impact of a cystitis clinical practice guideline on outcomes and costs of care in an HMO. The Joint Commission journal on quality improvement 1996;22:673-82.
-
(1996)
The Joint Commission Journal on Quality Improvement
, vol.22
, pp. 673-682
-
-
O'Connor, P.J.1
Solberg, L.I.2
Christianson, J.3
Amundson, G.4
Mosser, G.5
-
6
-
-
33847673653
-
Evaluating guidelines
-
DOI 10.1086/511878
-
Stamm WE. Evaluating guidelines. Clin Infect Dis 2007;44:775-6. (Pubitemid 46365299)
-
(2007)
Clinical Infectious Diseases
, vol.44
, Issue.6
, pp. 775-776
-
-
Stamm, W.E.1
-
7
-
-
0030791388
-
-
Fosfomycin for urinary tract infections, PMID: 9255237
-
Fosfomycin for urinary tract infections. Med Lett Drugs Ther 1997;39:66-8. PMID: 9255237.
-
(1997)
Med. Lett. Drugs Ther.
, vol.39
, pp. 66-68
-
-
-
8
-
-
0037260436
-
An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: The ECO.SENS project
-
DOI 10.1093/jac/dkg028
-
Kahlmeter G. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO. SENS Project. J Antimicrob Chemother 2003;51:69-76. (Pubitemid 36163829)
-
(2003)
Journal of Antimicrobial Chemotherapy
, vol.51
, Issue.1
, pp. 69-76
-
-
Kahlmeter, G.1
-
9
-
-
0141758347
-
Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECO. SENS study
-
Kahlmeter G. Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECO. SENS study. Int J Antimicrob Agents 2003;22(Suppl. 2): 49):49-52.
-
(2003)
Int. J. Antimicrob. Agents
, vol.22
, Issue.2 SUPPL.
, pp. 49-52
-
-
Kahlmeter, G.1
-
10
-
-
54249101741
-
Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): Implications for empiric therapy
-
Naber KG, Schito G, Botto H, Palou J, Mazzei T. Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy. Eur Urol 2008;54:1164-75.
-
(2008)
Eur. Urol.
, vol.54
, pp. 1164-1175
-
-
Naber, K.G.1
Schito, G.2
Botto, H.3
Palou, J.4
Mazzei, T.5
-
11
-
-
33747325623
-
Antibiotic resistance in Escherichia coli outpatient urinary isolates: Final results from the North American urinary tract infection collaborative alliance (NAUTICA)
-
Zhanel GG, Hisanaga TL, Laing NM, et al. Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Int J Antimicrob Agents 2006;27:468-75.
-
(2006)
Int. J. Antimicrob. Agents
, vol.27
, pp. 468-475
-
-
Zhanel, G.G.1
Hisanaga, T.L.2
Laing, N.M.3
-
12
-
-
77950260534
-
Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use
-
Sundqvist M, Geli P, Andersson DI, et al. Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use. J Antimicrob Chemother 2010;65:350-60.
-
(2010)
J. Antimicrob. Chemother.
, vol.65
, pp. 350-360
-
-
Sundqvist, M.1
Geli, P.2
Andersson, D.I.3
-
13
-
-
0037090334
-
Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan
-
DOI 10.1086/339491
-
Brown PD, Freeman A, Foxman B. Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan. Clin Infect Dis 2002;34:1061-6. (Pubitemid 34289678)
-
(2002)
Clinical Infectious Diseases
, vol.34
, Issue.8
, pp. 1061-1066
-
-
Brown, P.D.1
Freeman, A.2
Foxman, B.3
-
14
-
-
0242515959
-
Prior antimicrobial drug exposure: A risk factor for trimethoprim- sulfamethoxazole-resistant urinary tract infections
-
DOI 10.1093/jac/dkg146
-
Metlay JP, Strom BL, Asch DA. Prior antimicrobial drug exposure: a risk factor for trimethoprim-sulfamethoxazole-resistant urinary tract infections. J Antimicrob Chemother 2003;51:963-70. (Pubitemid 36503430)
-
(2003)
Journal of Antimicrobial Chemotherapy
, vol.51
, Issue.4
, pp. 963-970
-
-
Metlay, J.P.1
Strom, B.L.2
Asch, D.A.3
-
15
-
-
10744231870
-
Conventional and molecular epidemiology of trimethoprim-sulfamethoxazole resistance among urinary Escherichia coli isolates
-
DOI 10.1016/S0002-9343(03)00372-3
-
Burman WJ, Breese PE, Murray BE, et al. Conventional and molecular epidemiology of trimethoprim-sulfamethoxazole resistance among urinary Escherichia coli isolates. Am J Med 2003;115:358-64. (Pubitemid 37311252)
-
(2003)
American Journal of Medicine
, vol.115
, Issue.5
, pp. 358-364
-
-
Burman, W.J.1
Breese, P.E.2
Murray, B.E.3
Singh, K.V.4
Batal, H.A.5
MacKenzie, T.D.6
Ogle, J.W.7
Wilson, M.L.8
Reves, R.R.9
Mehler, P.S.10
-
16
-
-
40549090897
-
Risk factors for trimethoprim-sulfamethoxazole resistance in patients with acute uncomplicated cystitis
-
DOI 10.1128/AAC.01200-07
-
Colgan R, Johnson JR, Kuskowski M, Gupta K. Risk factors for trimethoprim-sulfamethoxazole resistance in patients with acute uncomplicated cystitis. Antimicrob Agents Chemother 2008;52:846-51. (Pubitemid 351358361)
-
(2008)
Antimicrobial Agents and Chemotherapy
, vol.52
, Issue.3
, pp. 846-851
-
-
Colgan, R.1
Johnson, J.R.2
Kuskowski, M.3
Gupta, K.4
-
17
-
-
53149119591
-
Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates
-
Johnson L, Sabel A, Burman WJ, et al. Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates. Am J Med 2008;121:876-84.
-
(2008)
Am. J. Med.
, vol.121
, pp. 876-884
-
-
Johnson, L.1
Sabel, A.2
Burman, W.J.3
-
18
-
-
53349095369
-
Prevalence and risk factor analysis of trimethoprim-sulfamethoxazoleand fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis
-
Talan DA, Krishnadasan A, Abrahamian FM, Stamm WE, Moran GJ. Prevalence and risk factor analysis of trimethoprim-sulfamethoxazoleand fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis. Clin Infect Dis 2008;47:1150-8.
-
(2008)
Clin. Infect. Dis.
, vol.47
, pp. 1150-1158
-
-
Talan, D.A.1
Krishnadasan, A.2
Abrahamian, F.M.3
Stamm, W.E.4
Moran, G.J.5
-
19
-
-
3442892932
-
Treatment of uncomplicated urinary tract infections in an era of increasing antimicrobial resistance
-
quiz 1053-4
-
Miller LG, Tang AW. Treatment of uncomplicated urinary tract infections in an era of increasing antimicrobial resistance. Mayo Clin Proc 2004;79:1048-53; quiz 1053-4.
-
(2004)
Mayo Clin. Proc.
, vol.79
, pp. 1048-1053
-
-
Miller, L.G.1
Tang, A.W.2
-
20
-
-
0037595456
-
Emerging antibiotic resistance in urinary tract pathogens
-
DOI 10.1016/S0891-5520(03)00006-0
-
Gupta K. Emerging antibiotic resistance in urinary tract pathogens. Infect Dis Clin North Am 2003;17:243-59. (Pubitemid 36760182)
-
(2003)
Infectious Disease Clinics of North America
, vol.17
, Issue.2
, pp. 243-259
-
-
Gupta, K.1
-
21
-
-
0036569748
-
Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens
-
DOI 10.1086/339812
-
Raz R, Chazan B, Kennes Y, et al. Empiric use of trimethoprim- sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens. Clin Infect Dis 2002;34:1165-9. (Pubitemid 34450662)
-
(2002)
Clinical Infectious Diseases
, vol.34
, Issue.9
, pp. 1165-1169
-
-
Raz, R.1
Chazan, B.2
Kennes, Y.3
Colodner, R.4
Rottensterich, E.5
Dan, M.6
Lavi, I.7
Stamm, W.8
Rohana, Y.9
Fainlaid, N.10
Bennet, L.11
Cantarell, M.12
Gvidolin, A.13
-
22
-
-
2442657715
-
"Collateral damage" from cephalosporin or quinolone antibiotic therapy
-
DOI 10.1086/382690
-
Paterson DL. "Collateral damage" from cephalosporin or quinolone antibiotic therapy. Clin Infect Dis 2004;38(Suppl. 4): S341-5. (Pubitemid 38669889)
-
(2004)
Clinical Infectious Diseases
, vol.38
, Issue.SUPPL. 4
-
-
Paterson, D.L.1
-
23
-
-
33645788333
-
Extended-spectrum β-lactamases and clinical outcomes: Current data
-
Ramphal R, Ambrose PG. Extended-spectrum β-lactamases and clinical outcomes: current data. Clin Infect Dis 2006;42(Suppl. 4): S164-72.
-
(2006)
Clin. Infect. Dis.
, vol.42
, Issue.4 SUPPL.
-
-
Ramphal, R.1
Ambrose, P.G.2
-
24
-
-
0141535257
-
Pivmecillinam-therapy of choice for lower urinary tract infection
-
Graninger W. Pivmecillinam-therapy of choice for lower urinary tract infection. Int J Antimicrob Agents 2003;22(Suppl. 2): 73):73-8.
-
(2003)
Int. J. Antimicrob. Agents
, vol.22
, Issue.2 SUPPL.
, pp. 73-78
-
-
Graninger, W.1
-
25
-
-
0025977919
-
Influence of fosfomycin on the intestinal and pharyngeal flora of man
-
Knothe H, Schafer V, Sammann A, Shah PM. Influence of fosfomycin on the intestinal and pharyngeal flora of man. Infection 1991;19:18-20.
-
(1991)
Infection
, vol.19
, pp. 18-20
-
-
Knothe, H.1
Schafer, V.2
Sammann, A.3
Shah, P.M.4
-
26
-
-
0030809280
-
Effect of norfloxacin, trimethoprim-sulfamethoxazole and nitrofurantoin on fecal flora of women with recurrent urinary tract infections
-
Mavromanolakis E, Maraki S, Samonis G, Tselentis Y. Effect of norfloxacin, trimethoprim-sulfamethoxazole and nitroffurantoin on fecal flora of women with recurrent urinary tract infections. J Chemother 1997;9:203-7. (Pubitemid 27288410)
-
(1997)
Journal of Chemotherapy
, vol.9
, Issue.3
, pp. 203-207
-
-
Mavromanolakis, E.1
Maraki, S.2
Samonis, G.3
Tselentis, Y.4
Cranidis, A.5
-
27
-
-
0035468838
-
Effect of antimicrobial agents on the ecological balance of human microflora
-
DOI 10.1016/S1473-3099(01)00066-4, PII S1473309901000664
-
Sullivan A, Edlund C, Nord C. Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect Dis 2001;1:101-14. (Pubitemid 33586045)
-
(2001)
Lancet Infectious Diseases
, vol.1
, Issue.2
, pp. 101-114
-
-
Sullivan, A.1
-
28
-
-
0036768969
-
Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women
-
Christiaens TC, De Meyere M, Verschraegen G, Peersman W, Heytens S, De Maeseneer JM. Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women. Br J Gen Pract 2002;52:729-34. (Pubitemid 36187595)
-
(2002)
British Journal of General Practice
, vol.52
, Issue.482
, pp. 729-734
-
-
Christiaens, T.C.M.1
De Meyere, M.2
Verschraegen, G.3
Peersman, W.4
Heytens, S.5
De Maeseneer, J.M.6
-
29
-
-
33847242164
-
Clinical and bacteriological outcome of different doses and duration of pivmecillinam compared with placebo therapy of uncomplicated lower urinary tract infection in women: The LUTIW project
-
Ferry SA, Holm SE, Stenlund H, Lundholm R, Monsen TJ. Clinical and bacteriological outcome of different doses and duration of pivmecillinam compared with placebo therapy of uncomplicated lower urinary tract infection in women: the LUTIW project. Scand J Prim Health Care 2007;25:49-57.
-
(2007)
Scand. J. Prim Health Care
, vol.25
, pp. 49-57
-
-
Ferry, S.A.1
Holm, S.E.2
Stenlund, H.3
Lundholm, R.4
Monsen, T.J.5
-
30
-
-
14644394267
-
Fluoroquinolone prescribing in the United States: 1995 to 2002
-
DOI 10.1016/j.amjmed.2004.09.015
-
Linder JA, Huang ES, Steinman MA, Gonzales R, Stafford RS. Fluoroquinolone prescribing in the United States: 1995 to 2002. Am J Med 2005;118:259-68. (Pubitemid 40312637)
-
(2005)
American Journal of Medicine
, vol.118
, Issue.3
, pp. 259-268
-
-
Linder, J.A.1
Huang, E.S.2
Steinman, M.A.3
Gonzales, R.4
Stafford, R.S.5
-
31
-
-
0010558947
-
Institute of medicine committee to advise the public health service on clinical practice guidelines
-
eds, Washington, DC: National Academy Press
-
Field MJ, Lohr KN, eds. Institute of Medicine Committee to Advise the Public Health Service on Clinical Practice Guidelines. Clinical practice guidelines: directions for a new program. Washington, DC: National Academy Press, 1990;55-77.
-
(1990)
Clinical Practice Guidelines: Directions for A New Program
, pp. 55-77
-
-
Field, M.J.1
Lohr, K.N.2
-
32
-
-
0018569077
-
The periodic health examination
-
Canadian Task Force on the Periodic Health Examination
-
Canadian Task Force on the Periodic Health Examination. The periodic health examination. Can Med Assoc J 1979;121(9) ; 1193-254.
-
(1979)
Can. Med. Assoc. J
, vol.121
, Issue.9
, pp. 1193-1254
-
-
-
33
-
-
0031944261
-
Efficacy and safety of norfloxacin 800 mg once-daily versus norfloxacin 400 mg twice-daily in the treatment of uncomplicated urinary tract infections in women: A double-blind, randomized clinical trial
-
Pimentel FL, Dolgner A, Guimaraes J, Quintas M, Mario-Reis J. Efficacy and safety of norfloxacin 800 mg once-daily versus norfloxacin 400 mg twice-daily in the treatment of uncomplicated urinary tract infections in women: a double-blind, randomized clinical trial. J Chemother 1998;10:122-7. (Pubitemid 28191105)
-
(1998)
Journal of Chemotherapy
, vol.10
, Issue.2
, pp. 122-127
-
-
Pimentel, F.L.1
Dolgner, A.2
Guimaraes, J.3
Quintas, M.4
Mario-Reis, J.5
-
34
-
-
79951815470
-
Guidelines on urological infections
-
EAU Guidelines Edition Presented At Barcelona ISBN 978-90-79754-70-0
-
Grabe M, Bishop MC, Bjerklund-Johansen TE, et al. Guidelines on urological infections. In EAU Guidelines edition presented at the 25th EAU Annual Congress, Barcelona 2010. ISBN 978-90-79754-70-0.
-
(2010)
The 25th EAU Annual Congress
-
-
Grabe, M.1
Bishop, M.C.2
Bjerklund-Johansen, T.E.3
-
35
-
-
6344260681
-
Comparison of short-term treatment regimen of ciprofloxacin versus long-term treatment regimens of trimethoprim/sulfamethoxazole or norfloxacin for uncomplicated lower urinary tract infections: A randomized, multicentre, open-label, prospective study
-
DOI 10.1093/jac/dkh414
-
Arredondo-Garcia JL, Figueroa-Damian R, Rosas A, Jauregui A, Corral M, Costa A, et al. Comparison of short-term treatment regimen of ciprofloxacin versus long-term treatment regimens of trimethoprim/sulfamethoxazole or norfloxacin for uncomplicated lower urinary tract infections: a randomized, multicentre, open-label, prospective study. J Antimicrob Chemother 2004;54:840-3. (Pubitemid 39386743)
-
(2004)
Journal of Antimicrobial Chemotherapy
, vol.54
, Issue.4
, pp. 840-843
-
-
Arredondo-Garcia, J.L.1
Figueroa-Damian, R.2
Rosas, A.3
Jauregui, A.4
Corral, M.5
Costa, A.6
Merlos, R.M.7
Rios-Fabra, A.8
Amabile-Cuevas, C.F.9
Hernandez-Oliva, G.M.10
Olguin, J.11
Cardenosa-Guerra, O.12
Leal del Rosal, P.13
Leal del Rosal, J.A.14
Urbina Rodriguez, R.E.15
Jaspersen Gastelum, J.16
Valle Gay, A.17
Leal, M.18
Aguirre Chavez, L.19
Ortega Rosas, R.20
Akle, D.21
Torres y Gutierrez Rubio, A.22
Orrantia Gradin, R.23
Ceja Rodriguez, J.J.24
Lara Perez Soto, C.25
Hurley, D.26
Sotres, D.27
Ponce de Leon, R.28
Leon, I.29
Villanueva, R.30
Manrique, J.J.31
Erdmenger, C.32
Hidalgo Portillo, E.33
Solano, J.D.34
Mendoza Roncancio, J.C.35
Castaneda, J.R.36
Santos, B.M.37
Jaramillo-Tobon, A.C.38
Cornejo Proano, F.39
Paz y Mino, N.40
Castellanos, F.41
Gallegos, B.42
Marcano, M.43
Arocha, I.44
more..
-
36
-
-
36148977902
-
Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women
-
DOI 10.1001/archinte.167.20.2207
-
Gupta K, Hooton TM, Roberts PL, Stamm WE. Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women. Arch Intern Med 2007;167:2207-12. (Pubitemid 350106740)
-
(2007)
Archives of Internal Medicine
, vol.167
, Issue.20
, pp. 2207-2212
-
-
Gupta, K.1
Hooton, T.M.2
Roberts, P.L.3
Stamm, W.E.4
-
37
-
-
0033016189
-
A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection
-
Iravani A, Klimberg I, Briefer C, Munera C, Kowalsky SF, Echols RM. A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection. J Antimicrob Chemother 1999;43(Suppl A): 67-75. (Pubitemid 29123504)
-
(1999)
Journal of Antimicrobial Chemotherapy
, vol.43
, Issue.SUPPL. A
, pp. 67-75
-
-
Iravani, A.1
Klimberg, I.2
Briefer, C.3
Munera, C.4
Kowalsky, S.F.5
Echols, R.M.6
-
38
-
-
0037417009
-
Cefpodoxime-proxetil versus trimethoprim-sulfamethoxazole for short-term therapy of uncomplicated acute cystitis in women
-
DOI 10.1128/AAC.47.3.897-900.2003
-
Kavatha D, Giamarellou H, Alexiou Z, et al. Cefpodoxime-proxetil versus trimethoprim-sulfamethoxazole for short-term therapy of uncomplicated acute cystitis in women. Antimicrob Agents Chemother 2003;47:897-900. (Pubitemid 36254212)
-
(2003)
Antimicrobial Agents and Chemotherapy
, vol.47
, Issue.3
, pp. 897-900
-
-
Kavatha, D.1
Giamarellou, H.2
Alexiou, Z.3
Vlachogiannis, N.4
Pentea, S.5
Gozadinos, T.6
Poulakou, G.7
Hatzipapas, A.8
Koratzanis, G.9
-
39
-
-
0032796432
-
Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection
-
Stein GE. Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection. Clin Ther 1999;21:1864-72.
-
(1999)
Clin. Ther.
, vol.21
, pp. 1864-1872
-
-
Stein, G.E.1
-
40
-
-
0032052545
-
A comparison between single-dose fosfomycin trometamol (Monuril∞) and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women
-
DOI 10.1016/S0924-8579(98)00021-1, PII S0924857998000211
-
Minassian MA, Lewis DA, Chattopadhyay D, Bovill B, Duckworth GJ, Williams JD. A comparison between single-dose fosfomycin trometamol (Monuril) and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women. Int J Antimicrob Agents 1998;10:39-47. (Pubitemid 28234359)
-
(1998)
International Journal of Antimicrobial Agents
, vol.10
, Issue.1
, pp. 39-47
-
-
Minassian, M.A.1
Lewis, D.A.2
Chattopadhyay, D.3
Bovill, B.4
Duckworth, G.J.5
Williams, J.D.6
-
41
-
-
77249086543
-
Fosfomycin: An old, new friend?
-
Popovic M, Steinort D, Pillai S, Joukhadar C. Fosfomycin: an old, new friend? Eur J Clin Microbiol Infect Dis 2010;29:127-42.
-
(2010)
Eur. J. Clin. Microbiol. Infect. Dis.
, vol.29
, pp. 127-142
-
-
Popovic, M.1
Steinort, D.2
Pillai, S.3
Joukhadar, C.4
-
42
-
-
52649112236
-
Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli
-
Rodriguez-Bano J, Alcala JC, Cisneros JM, et al. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Arch Intern Med 2008;168:1897-02.
-
(2008)
Arch. Intern. Med.
, vol.168
, pp. 1897-1802
-
-
Rodriguez-Bano, J.1
Alcala, J.C.2
Cisneros, J.M.3
-
43
-
-
0035990769
-
Three days of pivmecillinam or norfloxacin for treatment of acute uncomplicated urinary infection in women
-
Nicolle LE, Madsen KS, Debeeck GO, et al. Three days of pivmecillinam or norfloxacin for treatment of acute uncomplicated urinary infection in women. Scand J Infect Dis 2002;34:487-92.
-
(2002)
Scand. J. Infect. Dis.
, vol.34
, pp. 487-492
-
-
Nicolle, L.E.1
Madsen, K.S.2
Debeeck, G.O.3
-
44
-
-
0031658258
-
Treatment of community-acquired acute uncomplicated urinary tract infection with sparfloxacin versus ofloxacin
-
Henry D, Ellison W, Sullivan J, et al. Treatment of community-acquired acute uncomplicated urinary tract infection with sparfloxacin versus ofloxacin. The Sparfloxacin Multi Center UUTI Study Group. Antimicrob Agents Chemother 1998;42:2262-6. (Pubitemid 28420361)
-
(1998)
Antimicrobial Agents and Chemotherapy
, vol.42
, Issue.9
, pp. 2262-2266
-
-
Henry, D.1
Ellison, W.2
Sullivan, J.3
Mansfield, D.L.4
Magner, D.J.5
Dorr, M.B.6
Talbot, G.H.7
-
45
-
-
0032766826
-
Comparison of sparfloxacin and ciprofloxacin in the treatment of community-acquired acute uncomplicated urinary tract infection in women
-
DOI 10.1016/S0149-2918(99)80018-6
-
Henry DC, Nenad RC, Iravani A, et al. Comparison of sparfloxacin and ciprofloxacin in the treatment of community-acquired acute uncomplicated urinary tract infection in women. parfloxacin Multicenter Uncomplicated Urinary Tract Infection Study Group. Clin Ther 1999;21:966-81. (Pubitemid 29326157)
-
(1999)
Clinical Therapeutics
, vol.21
, Issue.6
, pp. 966-981
-
-
Henry, D.C.1
Nenad, R.C.2
Iravani, A.3
Tice, A.D.4
Mansfield, D.L.5
Magner, D.J.6
Dorr, M.B.7
Talbot, G.H.8
-
46
-
-
2942607768
-
Gatifloxacin 400 mg as a single shot or 200 mg once daily for 3 days is as effective as ciprofloxacin 250 mg twice daily for the treatment of patients with uncomplicated urinary tract infections
-
DOI 10.1016/j.ijantimicag.2003.12.017, PII S0924857904001311
-
Naber KG, Allin DM, Clarysse L, et al. Gatifloxacin 400 mg as a single shot or 200 mg once daily for 3 days is as effective as ciprofloxacin 250 mg twice daily for the treatment of patients with uncomplicated urinary tract infections. Int J Antimicrob Agents 2004;23:596-605. (Pubitemid 38759676)
-
(2004)
International Journal of Antimicrobial Agents
, vol.23
, Issue.6
, pp. 596-605
-
-
Naber, K.G.1
Allin, D.M.2
Clarysse, L.3
Haworth, D.A.4
James, I.G.V.5
Raini, C.6
Schneider, H.7
Wall, A.8
Weitz, P.9
Hopkins, G.10
Ankel-Fuchs, D.11
-
47
-
-
0036184901
-
Single-dose fluoroquinolone therapy of acute uncomplicated urinary tract infection in women: Results from a randomized, double-blind, multicenter trial comparing single-dose to 3-day fluoroquinolone regimens
-
DOI 10.1016/S0090-4295(01)01562-X, PII S009042950101562X
-
Richard GA, Mathew CP, Kirstein JM, Orchard D, Yang JY. Single-dose fluoroquinolone therapy of acute uncomplicated urinary tract infection in women: results from a randomized, double-blind, multicenter trial comparing single-dose to 3-day fluoroquinolone regimens. Urology 2002;59:334-9. (Pubitemid 34189729)
-
(2002)
Urology
, vol.59
, Issue.3
, pp. 334-339
-
-
Richard, G.A.1
Mathew, C.P.2
Kirstein, J.M.3
Orchard, D.4
Yang, J.Y.5
-
48
-
-
25844442538
-
Efficacy and safety of a novel once-daily extended-release ciprofloxacin tablet formulation for treatment of uncomplicated urinary tract infection in women
-
DOI 10.1128/AAC.49.10.4137-4143.2005
-
Fourcroy JL, Berner B, Chiang YK, Cramer M, Rowe L, Shore N. Efficacy and safety of a novel once-daily extended-release ciprofloxacin tablet formulation for treatment of uncomplicated urinary tract infection in women. Antimicrob Agents Chemother 2005;49:4137-43. (Pubitemid 41400956)
-
(2005)
Antimicrobial Agents and Chemotherapy
, vol.49
, Issue.10
, pp. 4137-4143
-
-
Fourcroy, J.L.1
Berner, B.2
Chiang, Y.-K.3
Cramer, M.4
Rowe, L.5
Shore, N.6
-
49
-
-
0036931775
-
Comparison of once-daily extended-release ciprofloxacin and conventional twice-daily ciprofloxacin for the treatment of uncomplicated urinary tract infection in women
-
DOI 10.1016/S0149-2918(02)80099-6
-
Henry DC Jr, Bettis RB, Riffer E, et al. Comparison of oncedaily extended-release ciprofloxacin and conventional twice-daily ciprofloxacin for the treatment of uncomplicated urinary tract infection in women. Clin Ther 2002;24:2088-104. (Pubitemid 36051533)
-
(2002)
Clinical Therapeutics
, vol.24
, Issue.12
, pp. 2088-2104
-
-
Henry Jr., D.C.1
Bettis, R.B.2
Riffer, E.3
Haverstock, D.C.4
Kowalsky, S.F.5
Manning, K.6
Hamed, K.A.7
Church, D.A.8
-
50
-
-
1442360078
-
Optimal duration of antibiotic therapy for uncomplicated urinary tract infection in older women: A double-blind randomized controlled trial
-
Vogel T, Verreault R, Gourdeau M, Morin M, Grenier-Gosselinl L, Rochette L. Optimal duration of antibiotic therapy for uncomplicated urinary tract infection in older women: a double-blind randomized controlled trial. CMAJ 2004;170:469-73. (Pubitemid 38293641)
-
(2004)
Canadian Medical Association Journal
, vol.170
, Issue.4
, pp. 469-473
-
-
Vogel, T.1
Verreault, R.2
Gourdeau, M.3
Morin, M.4
Grenier-Gosselin, L.5
Rochette, L.6
-
51
-
-
18544387783
-
Single-dose ciprofloxacin versus 3 days of norfloxacin in uncomplicated urinary tract infections in women
-
DOI 10.1046/j.1198-743x.2001.00359.x
-
Auquer F, Cordon F, Gorina E, Caballero JC, Adalid C, Batlle J. Singledose ciprofloxacin versus 3 days of norfloxacin in uncomplicated urinary tract infections in women. Clin Microbiol Infect 2002;8:50-4. (Pubitemid 34993761)
-
(2002)
Clinical Microbiology and Infection
, vol.8
, Issue.1
, pp. 50-54
-
-
Auquer, F.1
Cordon, F.2
Gorina, E.3
Caballero, J.C.4
Adalid, C.5
Batlle, J.6
-
52
-
-
13944278837
-
Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: A randomized trial
-
DOI 10.1001/jama.293.8.949
-
Hooton TM, Scholes D, Gupta K, Stapleton AE, Roberts PL, Stamm WE. Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial. JAMA 2005;293:949-55. (Pubitemid 40271126)
-
(2005)
Journal of the American Medical Association
, vol.293
, Issue.8
, pp. 949-955
-
-
Hooton, T.M.1
Scholes, D.2
Gupta, K.3
Stapleton, A.E.4
Roberts, P.L.5
Stamm, W.E.6
-
53
-
-
3042793159
-
Acute uncomplicated cystitis in an Era of increasing antibiotic resistance: A proposed approach to empirical therapy
-
DOI 10.1086/422145
-
Hooton TM, Besser R, Foxman B, Fritsche TR, Nicolle LE. Acute uncomplicated cystitis in an era of increasing antibiotic resistance: a proposed approach to empirical therapy. Clin Infect Dis 2004;39:75-80. (Pubitemid 38879552)
-
(2004)
Clinical Infectious Diseases
, vol.39
, Issue.1
, pp. 75-80
-
-
Hooton, T.M.1
Besser, R.2
Foxman, B.3
Fritsche, T.R.4
Nicolle, L.E.5
-
54
-
-
0033870179
-
Cefdinir versus cefaclor in the treatment of uncomplicated urinary tract infection
-
DOI 10.1016/S0149-2918(00)80054-5
-
Leigh AP, Nemeth MA, Keyserling CH, Hotary LH, Tack KJ. Cefdinir versus cefaclor in the treatment of uncomplicated urinary tract infection. Clin Ther 2000;22:818-25. (Pubitemid 30625914)
-
(2000)
Clinical Therapeutics
, vol.22
, Issue.7
, pp. 818-825
-
-
Leigh, A.P.1
Anne Nemeth, M.2
Keyserling, C.H.3
Hotary, L.H.4
Tack, K.J.5
-
55
-
-
0034701178
-
Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women: A randomized trial
-
Talan DA, Stamm WE, Hooton TM, et al. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial. JAMA 2000;283:1583-90. (Pubitemid 30161514)
-
(2000)
Journal of the American Medical Association
, vol.283
, Issue.12
, pp. 1583-1590
-
-
Talan, D.A.1
Stamm, W.E.2
Hooton, T.M.3
Moran, G.J.4
Burke, T.5
Iravani, A.6
Reuning-Scherer, J.7
Church, D.A.8
-
56
-
-
38649143127
-
A Double-Blind, Randomized Comparison of Levofloxacin 750 mg Once-Daily for Five Days With Ciprofloxacin 400/500 mg Twice-Daily for 10 Days for the Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
-
DOI 10.1016/j.urology.2007.09.002, PII S0090429507021139
-
Peterson J, Kaul S, Khashab M, Fisher AC, Kahn JB. A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis. Urology 2008;71:17-22. (Pubitemid 351173271)
-
(2008)
Urology
, vol.71
, Issue.1
, pp. 17-22
-
-
Peterson, J.1
Kaul, S.2
Khashab, M.3
Fisher, A.C.4
Kahn, J.B.5
-
57
-
-
0346499059
-
Once daily, extended release ciprofloxacin for complicated urinary tract infections and acute uncomplicated pyelonephritis
-
DOI 10.1097/01.ju.0000106191.11936.64
-
Talan DA, Klimberg IW, Nicolle LE, Song J, Kowalsky SF, Church DA. Once daily, extended release ciprofloxacin for complicated urinary tract infections and acute uncomplicated pyelonephritis. J Urol 2004;171:734-9. (Pubitemid 38090470)
-
(2004)
Journal of Urology
, vol.171
, Issue.2
, pp. 734-739
-
-
Talan, D.A.1
Klimberg, I.W.2
Nicolle, L.E.3
Song, J.4
Kowalsky, S.F.5
Church, D.A.6
-
58
-
-
1642277881
-
Gatifloxacin 200 mg or 400 mg once daily is as effective as ciprofloxacin 500 mg twice daily for the treatment of patients with acute pyelonephritis or complicated urinary tract infections
-
DOI 10.1016/j.ijantimicag.2003.09.002, PII S0924857903003364
-
Naber KG, Bartnicki A, Bischoff W, et al. Gatifloxacin 200 mg or 400 mg once daily is as effective as ciprofloxacin 500 mg twice daily for the treatment of patients with acute pyelonephritis or complicated urinary tract infections. Int J Antimicrob Agents 2004;23(Suppl. 1): S41-53. (Pubitemid 38376049)
-
(2004)
International Journal of Antimicrobial Agents
, vol.23
, Issue.SUPPL. 1
-
-
Naber, K.G.1
Bartnicki, A.2
Bischoff, W.3
Hanus, M.4
Milutinovic, S.5
Van Belle, F.6
Schonwald, S.7
Weitz, P.8
Ankel-Fuchs, D.9
-
59
-
-
17844401225
-
Fewer bacterial relapses after oral treatment with norfloxacin than with ceftibuten in acute pyelonephritis initially treated with intravenous cefuroxime
-
DOI 10.1080/003655401750173922
-
Cronberg S, Banke S, Bergman B, et al. Fewer bacterial relapses after oral treatment with norfloxacin than with ceftibuten in acute pyelonephritis initially treated with intravenous cefuroxime. Scand J Infect Dis 2001;33:339-43. (Pubitemid 32573982)
-
(2001)
Scandinavian Journal of Infectious Diseases
, vol.33
, Issue.5
, pp. 339-343
-
-
Cronberg, S.1
Banke, S.2
Bergman, B.3
Boman, H.4
Eilard, T.5
Elbel, E.6
Hugo-Persson, M.7
Johansson, E.8
Kuylenstierna, N.9
Lanbeck, P.10
Lindblom, A.11
Paulsen, O.12
Schonbeck, C.13
Walder, M.14
Wieslander, P.15
-
60
-
-
0036149661
-
Short-term effectiveness of ceftriaxone single dose in the initial treatment of acute uncomplicated pyelonephritis in women. A randomised controlled trial
-
Sanchez M, Collvinent B, Miro O, et al. Short-term effectiveness of ceftriaxone single dose in the initial treatment of acute uncomplicated pyelonephritis in women: a randomised controlled trial. Emerg Med J 2002;19:19-22. (Pubitemid 34092531)
-
(2002)
Emergency Medicine Journal
, vol.19
, Issue.1
, pp. 19-22
-
-
Sanchez, M.1
Collvinent, B.2
Miro, O.3
Horcajada, J.P.4
Moreno, A.5
Marco, F.6
Mensa, J.7
Milla, J.8
-
61
-
-
34547138656
-
Population-based epidemiologic analysis of acute pyelonephritis
-
DOI 10.1086/519268
-
Czaja CA, Scholes D, Hooton TM, Stamm WE. Population-based epidemiologic analysis of acute pyelonephritis. Clin Infect Dis 2007;45:273-80. (Pubitemid 47101021)
-
(2007)
Clinical Infectious Diseases
, vol.45
, Issue.3
, pp. 273-280
-
-
Czaja, C.A.1
Scholes, D.2
Hooton, T.M.3
Stamm, W.E.4
|